PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34237977-0	2021	Dexmedetomidine attenuates cerebral ischemia-reperfusion injury in rats by inhibiting the JNK pathway.	Dexmedetomidine	0-15	mitogen-activated protein kinase 8	Rattus norvegicus	90-93	
34237977-2	2021	This study was conducted to explore the effects of dexmedetomidine (Dex) on the c-Jun N-terminal kinase (JNK) pathway in CI/RI, and to provide a theoretical basis for the recovery of brain function after cerebral ischemia.	Dexmedetomidine	51-66	mitogen-activated protein kinase 8	Rattus norvegicus	80-103	
34237977-2	2021	This study was conducted to explore the effects of dexmedetomidine (Dex) on the c-Jun N-terminal kinase (JNK) pathway in CI/RI, and to provide a theoretical basis for the recovery of brain function after cerebral ischemia.	Dexmedetomidine	68-71	mitogen-activated protein kinase 8	Rattus norvegicus	80-103	
34237977-7	2021	RESULTS: Compared with the Sham group, the rats in I/R, I/R + Dex, I/R + Yoh + Dex, and I/R + SP600125 groups developed hemiparesis of the left forelimb at different levels with a higher neurological deficit score, brain water content, infarct volume, and markedly upregulated expression of cleaved caspase-3, p-JNK (P<0.05).	Dexmedetomidine	62-65	mitogen-activated protein kinase 8	Rattus norvegicus	312-315	
34237977-7	2021	RESULTS: Compared with the Sham group, the rats in I/R, I/R + Dex, I/R + Yoh + Dex, and I/R + SP600125 groups developed hemiparesis of the left forelimb at different levels with a higher neurological deficit score, brain water content, infarct volume, and markedly upregulated expression of cleaved caspase-3, p-JNK (P<0.05).	Dexmedetomidine	79-82	mitogen-activated protein kinase 8	Rattus norvegicus	312-315	
34237977-12	2021	Dex can alleviate cerebral CI/RI in rats by increasing alpha2-adrenergic receptor and blocking JNK phosphorylation and activation of caspase-3.	Dexmedetomidine	0-3	mitogen-activated protein kinase 8	Rattus norvegicus	95-98